Patriot Financial Group Insurance Agency’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-800
Closed -$24K 794
2022
Q2
$24K Sell
800
-110
-12% -$2.88K ﹤0.01% 945
2022
Q1
$29K Buy
910
+99
+12% +$3.41K 0.01% 954
2021
Q4
$36K Buy
811
+451
+125% +$21.4K 0.01% 995
2021
Q3
$18K Sell
360
-39
-10% -$2.2K ﹤0.01% 1252
2021
Q2
$31K Buy
399
+49
+14% +$3.03K 0.01% 1010
2021
Q1
$20K Hold
350
﹤0.01% 1087
2020
Q4
$29K Sell
350
-150
-30% -$9.07K 0.01% 859
2020
Q3
$18K Sell
500
-3,000
-86% -$90.3K 0.01% 821
2020
Q2
$85K Sell
3,500
-1,500
-30% -$35.3K 0.03% 383
2020
Q1
$88K Buy
5,000
+100
+2% +$2.09K 0.04% 338
2019
Q4
$85K Buy
4,900
+3,900
+390% +$64.9K 0.03% 368
2019
Q3
$15K Hold
1,000
0.01% 712
2019
Q2
$20K Hold
1,000
0.01% 640
2019
Q1
$21K Sell
1,000
-42,518
-98% -$890K 0.01% 540
2018
Q4
$899K Sell
43,518
-2,320
-5% -$42.1K 0.59% 26
2018
Q3
$967K Sell
45,838
-8,467
-16% -$140K 0.58% 22
2018
Q2
$828K Buy
54,305
+4,663
+9% +$87.9K 0.89% 20
2018
Q1
$931K Buy
+49,642
New +$1.02M 0.69% 26

Other funds holding DNLI

Patriot Financial Group Insurance Agency's DNLI Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Denali Therapeutics (DNLI) in Q3 2022, closing a stake of 800 shares — an estimated $24K sold.

Patriot Financial Group Insurance Agency first reported a position in DNLI in Q1 2018 and held it in 18 quarters. The position peaked at $967K in Q3 2018. 200 funds tracked by Wall St. Rank hold DNLI as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Denali Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 800 Denali Therapeutics shares in Q3 2022, an estimated $24K.
  • Patriot Financial Group Insurance Agency first reported a position in Denali Therapeutics in Q1 2018 and held it in 18 quarters.
  • Patriot Financial Group Insurance Agency's Denali Therapeutics position peaked at $967K in Q3 2018.
  • 200 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.